NHWA
LIVE

Serial Number

79018321

Owner

NHWA PHARMACEUTICAL CORPORATION

Filing Date

Mar 7, 2005

Add to watchlist:

No watchlists yet
View on USPTO

NHWA Trademark

Serial Number: 79018321 • Registration: 3206407

NHWA is a trademark filed by NHWA PHARMACEUTICAL CORPORATION on March 7, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NHWA PHARMACEUTICAL CORPORATION (3 trademarks)

Zhongshan North Road

Entity Type: 99

Trademark Details

Filing Date

March 7, 2005

Registration Date

February 6, 2007

Published for Opposition

November 21, 2006

Cancellation Date

March 8, 2025

Goods & Services

Medicines for human use and Chemico-pharmaceutical preparations, namely pharmaceutical preparations used to diminish inflammation, ease pain, relieve itch, allay a fever, stop bleeding, reduce tumefaction, dissolve gore; pharmaceutical preparations in the treatment of diseases caused by influenza, spasm, pain, hypomnesis, hindrance in the function of brain function, hindrance in upgrowth, ischemia and vasospasm; pharmaceutical preparations in the treatment of diseases caused by rheumatism; pharmaceutical preparations in the treatment of disorder in blood-lipid and blood pressure, convulsion, epilepsy, dementia, depression, mania, anxiety, hallucination, ataxia, constrain, schizophrenia, mental diseases, psychonosema, tremor, hypersensitivity, restlessness, scurvy, diabetes, obesity, neuropathy, psychoneurosis, neuronal diseases, parasitosis, heart attack, dermatosis, ophthalmopathy, otopathy, rhinopathy, laryngopathy, diseases in brain, diseases in lung, diseases in intestinal canal, diseases in stomach, diseases in liver, diseases in biliary tract, diseases in kidney, diseases in womb, cancer, stomatopathy, gynecological diseases, obstetrical diseases, angionosis, diseases in skeleton and bones, diseases in muscle, hematopathy, endocrinopathic diseases, diseases in urogenital system, diseases in genital system, respiratory failure, vomit; immuno-modulators; central nerve stimulants; hypnotics, sedatives, antithrombotics; pharmaceutical preparations in the treatment of lack of inorganic salts, sprain, wounds, debility, apoplexy, heatstroke; antidotes; anti-senile agents; Sanitary sterilizing preparations; medicinal herbs in dried or preserved form; ointment for pharmaceutical purposes, namely disinfectant ointments, antibacterial ointments, anti-inflammatory ointments, burn treatment ointments, analgesic ointments, antipruritic ointments; Isopropyl alcohol for medical use; Traditional Chinese medicines for the treatment to diminish inflammation, ease pain, relieve itch, allay a fever, stop bleeding, reduce tumefaction, dissolve gore; Traditional Chinese medicines for the treatment of diseases caused by influenza, spasm, pain, hypomnesis, hindrance in the function of brain function, hindrance in upgrowth, ischemia and vasospasm; Traditional Chinese medicines for the treatment of diseases caused by rheumatism; Traditional Chinese medicines for the treatment of disorder in blood-lipid and blood pressure, convulsion, epilepsy, dementia, depression, mania, anxiety, hallucination, ataxia, constrain, schizophrenia, mental diseases, psychonosema, tremor, hypersensitivity, restlessness, scurvy, diabetes, obesity, neuropathy, psychoneurosis, neuronal diseases, parasitosis, heart attack, dermatosis, ophthalmopathy, otopathy, rhinopathy, laryngopathy, diseases in brain, diseases in lung, diseases in intestinal canal, diseases in stomach, diseases in liver, diseases in biliary tract, diseases in kidney, diseases in womb, cancer, stomatopathy, gynecological diseases, obstetrical diseases, angionosis, diseases in skeleton and bones, diseases in muscle, hematopathy, endocrinopathic diseases, diseases in urogenital system, diseases in genital system, respiratory failure, vomit; immuno-modulators; central nerve stimulants; hypnotics, sedatives, antithrombotics; Traditional Chinese medicines for the treatment of lack of inorganic salts, sprain, wounds, debility, apoplexy, heatstroke; antidotes; anti-senile agents; Sanitary sterilizing preparations; Alcohols for pharmaceutical purposes, namely alcohols for the treatment of diseases caused by rheumatism, arthritis, diseases in lung, diseases in intestinal canal, diseases in stomach, diseases in liver, diseases in biliary tract, diseases in kidney, cancer, stomatopathy, gynecological diseases, angionosis, diseases in skeleton and bones, diseases in muscle, diseases in urogenital system, immuno-modulators;dietetic foods adapted for medical use

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Sep 29, 2025 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 29, 2023 NREP
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sep 24, 2015 DENC
DEATH OF INTERNATIONAL REGISTRATION
Sep 24, 2015 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Feb 6, 2015 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Dec 6, 2014 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 6, 2014 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 4, 2014 INTR
CANCELLED SECTION 71
Oct 4, 2013 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
May 23, 2008 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 28, 2007 FICS
FINAL DISPOSITION PROCESSED
Aug 28, 2007 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 23, 2007 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 6, 2007 R.PR
PUBLISHED FOR OPPOSITION
Nov 21, 2006 PUBO
NOTICE OF PUBLICATION
Nov 1, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 28, 2006 PREV
ASSIGNED TO LIE
Sep 26, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 21, 2006 TROA
FINAL REFUSAL MAILED
May 17, 2006 CNFR
FINAL REFUSAL WRITTEN
May 17, 2006 CNFR
ASSIGNED TO EXAMINER
May 9, 2006 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 2, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2006 TROA
REFUSAL PROCESSED BY IB
Jan 27, 2006 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 9, 2006 RFCS
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 30, 2005 RFCR
NON-FINAL ACTION WRITTEN
Dec 29, 2005 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2005 DOCK
NEW APPLICATION ENTERED
Dec 27, 2005 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2005 REPR